Polynucleotide encoding human adenylylcyclase VI and uses...

Details Polynucleotide encoding human adenylylcyclase VI and uses... Polynucleotide encoding human adenylylcyclase VI and uses...

2007-06-26

2007-06-26

Wilson, Michael C. (Department: 1632)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S093100, C424S093210, C536S023100, C514S04400A

Reexamination Certificate

active

10942072

ABSTRACT:
The present invention relates to polynucleotides encoding human adenylylcyclase VI and uses thereof for enhancing cardiac function. The present invention can thus be used in the treatment of heart disease, especially congestive heart failure.

REFERENCES:
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5283185 (1994-02-01), Epand et al.
patent: 5334521 (1994-08-01), Ishikawa
patent: 5334761 (1994-08-01), Gebeyehu et al.
patent: 5459127 (1995-10-01), Felgner et al.
patent: 5578481 (1996-11-01), Ishikawa
patent: 5792453 (1998-08-01), Hammond et al.
patent: 6033885 (2000-03-01), Latta et al.
patent: 6034071 (2000-03-01), Iyengar
patent: 6107076 (2000-08-01), Tang et al.
patent: 6174871 (2001-01-01), Hammond et al.
patent: 6294377 (2001-09-01), Haddada et al.
patent: 6306830 (2001-10-01), Hammond et al.
patent: 6465237 (2002-10-01), Tomlinson
patent: 2003/0096787 (2003-05-01), Perricaudet et al.
patent: 0 529 662 (1993-03-01), None
patent: 0 543 137 (1993-05-01), None
patent: WO-91/06309 (1991-05-01), None
patent: WO-91/17424 (1991-11-01), None
patent: WO-92/08796 (1992-05-01), None
patent: WO-93/05061 (1993-03-01), None
patent: WO-93/19768 (1993-10-01), None
patent: WO-93/25673 (1993-12-01), None
patent: WO-94/11506 (1994-05-01), None
patent: WO-94/26914 (1994-11-01), None
patent: WO-94/28143 (1994-12-01), None
patent: WO-95/00655 (1995-01-01), None
patent: WO-95/02697 (1995-01-01), None
patent: WO-95/02698 (1995-01-01), None
patent: WO-95/13365 (1995-05-01), None
patent: WO-95/13392 (1995-05-01), None
patent: WO-95/16772 (1995-06-01), None
patent: WO-95/17373 (1995-06-01), None
patent: WO-95/23867 (1995-09-01), None
patent: WO-95/25071 (1995-09-01), None
patent: WO-95/28494 (1995-10-01), None
patent: WO-95/34647 (1995-12-01), None
patent: WO-96/00295 (1996-01-01), None
patent: WO-96/01840 (1996-01-01), None
patent: WO-96/08260 (1996-03-01), None
patent: WO-96/17947 (1996-06-01), None
patent: WO-96/26742-AI (1996-09-01), None
patent: WO-97/12050 (1997-04-01), None
patent: WO-97/16169 (1997-05-01), None
patent: WO-97/16170 (1997-05-01), None
patent: WO-97/17937 (1997-05-01), None
patent: WO-97/17937 (1997-05-01), None
patent: WO-9810085 (1998-03-01), None
patent: WO-99/01546 (1999-01-01), None
patent: WO-99/01547 (1999-01-01), None
patent: WO-99/40945 (1999-08-01), None
patent: WO-99/40945 (1999-08-01), None
US 5,891,715, 04/1999, Haddada et al. (withdrawn)
Abbas, A. et al. (1991).Cellular and Molecular Immunology, W.B. Saunders Co., pp. ix-xi (Table of Contents).
Abbas, A. et al. (1994).Cellular and Molecular Immunology 2nd Ed, W.B. Saunders Co., pp. xi-xiii (Table of Contents).
Adams, R.L.P. (1990). “Cell Culture for Biochemists,”In Laboratory Techniques in Biochemistry and Molecular Biology.Burdon, R.H. and van Knippenberg, P.H., eds., Elsevier Science Publishers, pp. xi-xvii (Table of Contents).
Alousi, A.A. et al. (1991). “Stoichiometry of Receptor-Gs-Adenylate Cyclase Interactions,”FASEB J.5(9):2300-2304.
Ausubel, F. et al. (eds.), (1987).Current Protocols in Molecular Biology, Wiley: New York, pp. xvii-xxii (Table of Contents).
Avidor-Reiss, T. et al. (1997). “Opiate-Induced Adenylyl Cyclase Superactivation is Isozyme-Specific,”J. Biol. Chem.272(8):5040-7.
Baughman, K. (1995). “New Medical Therapies for Advanced Left Ventricular Dysfunction,”Cardiology Clinics13(1):27-34.
Benovic, J.L. (1991). “Purification and Characterization of Beta-Adrenergic Receptor Kinase,”Methods Enzymol.200:351-362.
Berns (1990). “Chapter 62, Parvoviridae and Their Replication,”In Fields Virology, Fields, B. N. et al., eds., Raven Press, New York, pp. 1743-1763.
Bers, D.M. (1979). “Isolation and Characterization of Cardiac Sarcolemma,”Biochim Biophys Acta.555:131-146.
Bloom, W. et al. (1975).A Textbook of Histology, 10th Ed., W.B. Saunders Co., Philadelphia, pp. vii-xv (Table of Contents).
Bohm, M. (1995). “Alterations of Beta-Adrenoceptor-G-Protein-Regulated Adenylyl Cyclase in Heart Failure,”Mol Cell Biochem.147(1-2):147-60.
Bond, R.A. et al. (1995). “Physiological Effects of Inverse Agonists in Transgenic Mice with Myocardial Overexpression of the Beta 2-Adrenoceptor,”Nature374(6519):272-276.
Bothwell, A. et al. eds., (1990).Methods for Cloning and Analysis of Eukaryotic Genes, Bartlett Publ., pp. iii-x (Table of Contents).
Bradford, M.M. (1976). “A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding,”Anal Biochem72:248-254.
Braunwald, E. ed. (1988). “Chapter 16: Clinical Manifestations of Heart Failure”In Heart Disease, a Text book of Cardiovascular Medicine, W.B. Saunders, Philadelphia, pp. 426, 471-484.
Brigham, K.L. et al. (1993). “Cationic Liposomes and DNA Delivery,”J. Liposome Res.3:31-49.
Bristow, M.R. et al. (1982). “Decreased Catecholamine Sensitivity and Beta-Adrenergic-Receptor Density in Failing Human Hearts,”N Engl J Med307(4):205-211.
Bristow, M.R. et al. (1986). “Beta 1- and Beta 2-Adrenergic-Receptor Subpopulations in Nonfailing and Failing Human Ventricular Myocardium: Coupling of Both Receptor Subtypes to Muscle Contraction and Selective Beta 1-Receptor Down-Regulation in Heart Failure,”Circ Res59(3):297-309.
Bristow, M.R. et al. (1989). “J1andJ2-Adrenergic Receptor-Mediated Adenylate Cyclase Stimulation in Nonfailing and Failing Human Ventricular Myocardium,”Mol. Pharm.35(3):295-303.
Bristow, M.R. et al. (1993). “ReducedJ1Receptor Messenger RNA Abundance in the Failing Human Heart,”J. Clin. Invest.92(6):2737-2745.
Brown, T. ed. (1991),Essential Molecular Biology, IRL Press, Table of Contents, pp. ix-xv.
Bullock, G. and Petrusz, P. (eds.), (1982).Techniques in Immunocytochemistry vol. 1, Academic Press, pp. xi-xii (Table of Contents).
Bullock, G. and Petrusz, P. (eds.), (1983).Techniques in Immunocytochemistry vol. 2, Academic Press, pp. ix-x (Table of Contents).
Bullock, G. and Petrusz, P. (eds.), (1985).Techniques in Immunocytochemistry vol. 3, Academic Press, pp. v-vi (Table of Contents).
Bullock, G. and Petrusz, P. (eds.), (1989).Techniques in Immunocytochemistry vol. 4, Academic Press, pp. v-vi (Table of Contents).
Burns, J.C. et al. (1993). “Vesicular Stomatitis Virus G Glycoprotein Pseudotyped Retroviral Vectors: Concentration to Very High Titer and Efficient Gene transfer Into Mammalian and Nonmammalian Cells,”Proc. Natl. Acad. Sci.(USA) 90(17):8033-8037.
Butler, M. ed. (1991).Mammalian Cell Biotechnology, A Practical Approach, IRL Press: Oxford, pp. ix-xiv (Table of Contents).
Calderone, A. et al. (1991). “Dysfunction of the Beta- and Alpha-Adrenergic Systems in a Model of Congestive Heart Failure,”Circ Res69(2):332-343.
Carter, B.J. et al. (1990). “Chapter 11, AAV DNA Replication, Integration, and Genetics,”In Handbook of Parvoviruses, vol. 1., Tijssen, P. ed., CRC Press: Boca Raton FL, pp. 169-228.
Carter, B.J. (1992). “Adeno-Associated Virus Vectors,”Curr. Opin. Biotechnol.3(5):533-539.
Chatterjee, S. et al. (1995). “Strategies for Efficient Gene Transfer into Hematopoietic Cells: The Use of Adeno-Associated Virus Vectors in Gene Therapy,”Ann. NY. Acad. Sci.770:79-90.
Chen, Z. et al. (1995). “Expression of Type V Adenylyl Cyclase is Required for Epidermal Growth Factor-Mediated Stimulation of cAMP Accumulation,”J Biol Chem270(46):27525-27530.
Chomczynski, P. et al. (1987). “Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction,”Anal Biochem162(1):156-159.
Chonn, A. et al. (1995). , “Recent Advances in Liposomal Drug-Delivery Systems.”Curr Opinion Biotech6(6):698-708.
Coligan, J. et al. eds., (1991).Current Protocols in Immunologyvol. 1. Wiley, pp. 1-9 (Table of Contents).
Crystal, R.G. (1995). “Transfer of Genes to Humans: Early Lessons and Obstacles to Success,”Science270(5235):404-410.
Curiel, D.

Affiliated with

Also associated with

Rating

Polynucleotide encoding human adenylylcyclase VI and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polynucleotide encoding human adenylylcyclase VI and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotide encoding human adenylylcyclase VI and uses... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3816167